Intestinal Lipase Inhibitor
6 drugs across 2 manufacturers|1 Generic,5 Brand
The Intestinal Lipase Inhibitor class contains 6 NDCs from 2 manufacturers (1 generic, 5 brand), at an average NADAC of $2.24 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
6
1G / 5B
Manufacturers
2
Avg $2.2408/unit
Avg 7d Change
+0.35%
Across 2 drugs with changes
7d Activity
of 6 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ORLISTAT 120 MG CAPSULE orlistat | $7.0033 per EA | +0.81% |
XENICAL 120 MG CAPSULE orlistat | $4.5986 per EA | -0.12% |
ALLI 60 MG CAPSULE orlistat | $0.4820 per EA | — |
ALLI 60 MG CAPSULE orlistat | $0.4536 per EA | — |
ALLI 60 MG CAPSULE orlistat | $0.4536 per EA | — |
ALLI 60 MG CAPSULE orlistat | $0.4536 per EA | — |
Frequently Asked Questions
How many drugs are in the Intestinal Lipase Inhibitor class?
The Intestinal Lipase Inhibitor class contains 6 NDCs from 2 manufacturers — 1 generic and 5 brand products.
What is the average price of Intestinal Lipase Inhibitor drugs?
The average NADAC for the Intestinal Lipase Inhibitor class is $2.2408 per unit across 6 NDCs.
Is generic cheaper than brand in the Intestinal Lipase Inhibitor class?
Among products priced per EA, the average generic NADAC in this class is $7.0033, versus $1.2883 for brand — brand is currently about 82% cheaper on average.
Which manufacturers make Intestinal Lipase Inhibitor drugs?
2 manufacturers make drugs in the Intestinal Lipase Inhibitor class. Ranked by number of NDCs, the largest are Haleon US Holdings LLC (4), H2-Pharma LLC (2).
How has Intestinal Lipase Inhibitor pricing changed recently?
Over the past 7 days, 1 NDC in this class rose and 1 fell, with a class-wide average change of +0.3%.